login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CAMP4 THERAPEUTICS CORP (CAMP) Stock News
USA
-
Nasdaq
- NASDAQ:CAMP -
US13463J1016
-
Common Stock
3.595
USD
-0.05 (-1.51%)
Last: 12/9/2025, 11:15:03 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CAMP Latest News, Press Relases and Analysis
All
Press Releases
10 days ago - By: The Motley Fool
- Mentions:
CNTA
SKYE
TRDA
PHVS
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
21 days ago - By: The Motley Fool
- Mentions:
VKTX
SKYE
TRDA
PHVS
...
5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?
25 days ago - By: CAMP4 Therapeutics
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
8 months ago - By: Benzinga
- Mentions:
GNFT
EWTX
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2
25 days ago - By: CAMP4 Therapeutics
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: CAMP4 Therapeutics
CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
a month ago - By: CAMP4 Therapeutics
CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
2 months ago - By: CAMP4 Therapeutics
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
2 months ago - By: CAMP4 Therapeutics
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
3 months ago - By: Benzinga
- Mentions:
KEQU
BLRX
VNRX
RNA
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
3 months ago - By: CAMP4 Therapeutics
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
3 months ago - By: CAMP4 Therapeutics
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
4 months ago - By: CAMP4 Therapeutics
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
4 months ago - By: CAMP4 Therapeutics
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
7 months ago - By: CAMP4 Therapeutics
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American
7 months ago - By: CAMP4 Therapeutics
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American
7 months ago - By: CAMP4 Therapeutics
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
7 months ago - By: CAMP4 Therapeutics
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
7 months ago - By: CAMP4 Therapeutics
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
7 months ago - By: CAMP4 Therapeutics
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
9 months ago - By: CAMP4 Therapeutics
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
9 months ago - By: CAMP4 Therapeutics
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
9 months ago - By: CAMP4 Therapeutics
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
9 months ago - By: CAMP4 Therapeutics
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
10 months ago - By: CAMP4 Therapeutics
CAMP4 to Participate in Upcoming Investor Conferences
10 months ago - By: CAMP4 Therapeutics
CAMP4 to Participate in Upcoming Investor Conferences
Please enable JavaScript to continue using this application.